MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +65

MetLife stock holds near its 52-week high as analysts stay upbeat

AI-generated analysis

📈 MetLife stock traded at USD 97.08 on September 18, 2026, placing it just below its 52-week high of USD 100.93.

💰 Q2 2026 EPS reached USD 2.43, beating the consensus estimate of USD 2.30 by USD 0.13.

📊 Revenue grew 10.5 percent year over year to USD 13.52 billion in the second quarter of 2026.

🏆 Net margin improved to 4.57 percent with return on equity reaching 23.39 percent for the quarter.

🎯 The average 12-month analyst price target is USD 102.77, suggesting upside potential from current levels.

📉 Wall Street Zen cut MetLife to Hold, though the broader consensus remains Moderate Buy with 11 buy ratings.

🚀 Morgan Stanley raised its price target from USD 103.00 to USD 111.00 following recent performance.

🏦 Wells Fargo lifted its price target from USD 101.00 to USD 109.00, reinforcing bullish sentiment.

📅 The next earnings report is scheduled for November 9, 2026, providing a key catalyst for traders.

📉 Daily volume was 7.31 million shares with the stock trading in a 50-day range of USD 92.24 to USD 100.06.

Bullish Signals
  • MetLife reported Q2 2026 EPS of USD 2.43, beating the consensus estimate of USD 2.30 by USD 0.13.
  • Revenue rose 10.5 percent year over year to USD 13.52 billion in the second quarter of 2026.
  • Net margin expanded to 4.57 percent while return on equity reached 23.39 percent for the quarter.
  • The stock is trading near its 52-week high, indicating strong investor confidence in the company's fundamentals.
  • Morgan Stanley raised its price target from USD 103.00 to USD 111.00, signaling increased bullishness.
  • Wells Fargo lifted its price target from USD 101.00 to USD 109.00, supporting the Moderate Buy consensus.
  • The average 12-month analyst price target of USD 102.77 suggests potential upside from the current trading price.
Risk Factors
  • Wall Street Zen cut MetLife's rating to Hold, introducing a dissenting voice in the analyst consensus.
  • The stock is trading approximately USD 3.85 below its 52-week high, limiting immediate momentum near resistance levels.
Full Analysis
MetLife Inc. stock traded at USD 97.08 on September 18, 2026, positioning the life insurer near its 52-week high of USD 100.93 with a market capitalization of USD 62.47 billion. The company recently reported strong financial performance for the second quarter of 2026, beating analyst expectations and demonstrating robust operational metrics that support its current valuation. For the second quarter of 2026, MetLife earned USD 2.43 per share, surpassing the consensus estimate of USD 2.30 by USD 0.13. Revenue increased 10.5 percent year over year to reach USD 13.52 billion, while net margins improved to 4.57 percent and return on equity climbed to 23.39 percent, highlighting a healthy operating profile. Analyst sentiment remains largely positive despite the stock trading close to its yearly peak. The consensus rating is Moderate Buy with an average 12-month price target of USD 102.77. While Wall Street Zen recently cut its rating to Hold, major institutions like Morgan Stanley and Wells Fargo have raised their price targets to USD 111.00 and USD 109.00 respectively. MetLife is scheduled to report earnings again on November 9, 2026. Until then, investors are focusing on the gap between the current stock price and the analyst consensus target, as well as the proximity to the 52-week high, which serves as a key reference point for near-term trading activity.